Regulatory guidance and project coordination

Product Compliance And Certification For Hair Dye In The USA

Scope and evidence must be confirmed before any paid tests or filings.

A U.S. hair dye launch is not a single certification exercise. Start with where the color goes, which chemical family creates it, how long the effect lasts and what the label promises. Those facts determine the FDA cosmetic, color-additive, MoCRA, labeling and import gates; a medical claim can add drug rules.

Classify the actual dye, not the marketing name

Cosmetic-only scalp coloring generally follows the cosmetic pathway. A promise to treat a scalp disease, restore hair growth or otherwise alter body structure or function may make the product a drug as well as a cosmetic. Review the website, retailer listing and salon training, not just the carton. A color shampoo, peroxide developer, henna powder and eyebrow tint must not be assigned one route merely because all are called “hair dye.”

Collect the complete formulation (including developer and any mixed-in products), coloring mechanism, application site, rinse-off instructions, duration of visible effect, all claims and intended buyer (consumer versus professional). The term “coal-tar hair dye” is a specific U.S. legal category for synthetic-organic dyes, not a statement that the product literally contains coal tar.

U.S. hair-color regulatory route matrix

The following is a classification triage, not an approval finding. A single kit may trigger several rows; resolve every relevant trigger before artwork or U.S. shipment.

Hair-color scenarioRegulatory triggerNext decision / launch gate
Permanent or semi-permanent synthetic-organic scalp dyePotential coal-tar hair-dye exception; routine cosmetic and MoCRA duties still apply.Confirm dye chemistry, statutory caution and adequate skin-test directions; assess permanence for the MoCRA exemption.
Henna, plant-derived or mineral scalp colorCoal-tar exception is not automatic; color-additive rules may apply.Verify each coloring substance is FDA-listed for the precise intended hair use and meets restrictions.
Bleach, developer and multi-part coloring kitFinal used mixture, irritation potential and kit labeling create exposure and warning questions.Assess all supplied components, mixing ratio, contact time and separate/container labeling.
Color-depositing shampoo, rinse or temporary aerosolRinse-off pattern, color mechanism and aerosol format can change the obligations.Classify ingredient-by-ingredient; assess aerosol warnings where applicable and actual duration of the result.
Eyebrow or eyelash tintThe scalp coal-tar exemption does not extend to brows or lashes.Do not repurpose scalp dye; check the narrow professional-use silver-nitrate authorization in 21 CFR 73.2550, if relevant.
Dye marketed to treat scalp disease or regrow hairTherapeutic/structure-function claims can trigger drug status.Stop the cosmetic-only launch analysis and separately determine the applicable drug pathway.

The FDA listing for henna (21 CFR 73.2190) allows hair coloring, not eyebrow, eyelash or other eye-area dyeing; “natural” does not expand that use. The separate eyebrow/eyelash option in 21 CFR 73.2550 is limited to a silver-nitrate viscous gel (maximum 4% by weight, viscosity 120–180 Pa·s), applied by a professional for no more than one minute and removed immediately. It is not for people under 16 or for distribution or direct sale to consumers; its specified warnings and directions must also be met. Do not treat this as a general approval for salon brow dyes.

When the coal-tar dye exception applies—and when it does not

Two different rules must be kept separate. Under FD&C Act §601(e), the coal-tar hair-dye category is excepted from the ordinary color-additive preapproval requirement. Separately, §601(a) restricts FDA action based on a particular safety-related adulteration ground only if the label carries the statutory caution and adequate directions for a preliminary skin test accompany the product. The warning is a condition of that specific §601(a) protection, not the source of a general permission to use an otherwise unapproved colorant. Neither provision is an FDA determination that the formula is safe. The U.S. statutory caution reads:

Caution - This product contains ingredients which may cause skin irritation on certain individuals and a preliminary test according to accompanying directions should first be made. This product must not be used for dyeing the eyelashes or eyebrows; to do so may cause blindness.

Do not replace that English legal wording with an informal allergy disclaimer. The exception does not excuse other harmful ingredients, deceptive claims, defective labeling or MoCRA obligations. Plant and mineral colorants must be separately checked under FDA color-additive listings; some listed colors require batch certification. Lead acetate is no longer permitted as a color additive in progressive scalp hair dyes (effective January 6, 2022). The special cancer warning in 21 CFR 740.18 is an additional ingredient-specific check, not a universal warning for all dyes.

Synthetic-organic coal-tar hair dyes may be temporary, semi-permanent or permanent: duration alone does not decide that category. Conversely, the more-than-24-hour condition concerns a separate MoCRA small-business exemption and does not authorize a colorant.

MoCRA: responsibility, listings and the 24-hour trap

The responsible person under MoCRA is the manufacturer, packer or distributor named on the cosmetic label; it is not automatically the importer or the factory. Where no exemption applies, manufacturers/processors register facilities (and renew biennially), while the responsible person lists marketed cosmetic products and updates listings annually. Foreign facilities required to register supply a U.S. agent; a U.S. agent is not the same as the label’s responsible person. FDA registration/listing numbers are not certificates or FDA approvals.

Do not assume a small brand is exempt. MoCRA’s small-business exemption from facility registration, listing and future GMP requirements is unavailable for products intended to alter appearance for more than 24 hours when consumer removal is not part of customary use—potentially including permanent or certain semi-permanent dyes. Assess the actual product and the statutory criteria; a washable one-day spray may differ. Even where an exemption applies, safety substantiation and serious-adverse-event reporting still require separate review. Responsible persons report qualifying serious events to FDA within 15 business days.

To evaluate the small-business exemption, §612 (21 U.S.C. §364h) first requires average annual U.S. sales of cosmetic products over the preceding three years below $1 million, adjusted for inflation, as well as absence of the disqualifying product categories. That turnover test cannot save a qualifying long-lasting dye. Separately, MoCRA's safety-substantiation rule has its own hair-dye exception: under §608(b) (21 U.S.C. §364d(b)), §608(a)'s adequate-safety-substantiation requirement does not apply to a coal-tar hair dye that otherwise complies with §601(a), but its responsible person must still retain records related to that product's safety. Other cosmetics remain subject to the general §608(a) rule. Neither exception amounts to an FDA finding of safety or removes serious-adverse-event duties. The 15-business-day reporting clock begins when the responsible person receives the serious-adverse-event report.

For cosmetic product listing, FDA Form 5067 permits a single submission covering identical formulas or formulas differing only in color, fragrance, flavor or quantity; it does not permit unrelated kit configurations to be treated as identical. Maintain a shade-by-shade ingredient map and confirm how each product is represented in the submission.

Supplier evidence file tailored to hair color

Build a traceable release dossier by formula, shade and kit configuration. This is a practical evidence map, not a government-prescribed universal test panel:

  • Full quantitative formula, colorant identity/function, CAS or recognized ingredient names, supplier specifications, impurities and changes by shade.
  • Intended use evidence: scalp versus brow/lash, consumer or salon channel, color persistence, mixing ratio, contact time and skin-test directions.
  • Ingredient-by-ingredient FDA color-additive listing/restriction analysis and, where applicable, FDA batch-certification evidence; a foreign approval is not a substitute.
  • Scientifically relevant safety substantiation for normal and foreseeable use, including irritation/sensitization exposure and finished-mixture compatibility; justify selected tests rather than assuming one test is legally mandatory.
  • Finished artwork for every container and carton, ingredient declaration where required, English statutory caution if applicable, net contents, business identity and adverse-event reporting contact.
  • MoCRA facility-versus-responsible-person assignment, registration/listing assessment and records, supplier/brand complaint handling and serious-event escalation procedure.
  • Import documents, accurate origin marking and product description; preserve lot/shade traceability and the change log for formula or claims.

Packaging, advertising and import release gates

Before label approval, compare ingredient declaration, identity, net quantity, manufacturer/packer/distributor business identity and warnings with 21 CFR 701/740 and MoCRA section 609. Retail cosmetic ingredient labeling and professional-only channels may differ; do not assume the salon channel excuses other requirements. The label needs a domestic address, domestic phone number or electronic contact (for example a website) for adverse-event reports. Mandatory U.S. label text must be in English.

If a cosmetic is intended only for use by licensed professionals, 21 U.S.C. §364e(c) also requires a clear, prominent professional-only label statement; a salon sales channel alone does not resolve who may lawfully use it.

For advertising, independently substantiate objective claims such as “PPD-free,” “hypoallergenic,” “ammonia-free” or “lasts six weeks”; such wording is not an exemption from safety evaluation or skin-test instructions. FTC truth-in-advertising obligations are separate from FDA labeling. Imported cosmetics must meet the same substantive U.S. FDA rules as domestic goods; truthful entry descriptions and colorant records help avoid detention. An ISO 22716 certificate may assist supplier assessment but is not FDA product approval or a substitute for applicable MoCRA duties.

Two different label fields must not be conflated: the manufacturer, packer or distributor name and place of business under 21 CFR 701.12, and the domestic address, domestic phone number or electronic contact for adverse-event reports under MoCRA section 609(a). If other languages appear on the label or labeling, check the corresponding translation requirements for mandatory information under 21 CFR 701.2; English text alone may not suffice.

Decision sequence and changes that reopen review

Use a hold-and-release order; do not print or ship while a critical branch remains unanswered:

  1. Freeze each SKU’s intended use, sales claims, dye chemistry, developer and exposure conditions.
  2. Select the cosmetic-only, cosmetic-plus-drug or eye-area route and document why alternatives were rejected.
  3. Check every colorant and the exact coal-tar exception / statutory warning / skin-test package, as applicable.
  4. Determine MoCRA responsible person, affected facilities, >24-hour exemption criterion and required filings.
  5. Approve the safety file, U.S. pack copy, claim evidence and import data before commercial release.

Reopen the analysis when a shade changes colorants, the developer concentration changes, a salon dye is sold directly to consumers, a “temporary” product claims longer wear, an eyebrow use is added, or therapeutic language appears. None of those changes can be cleared from the trade name alone.

Do not import requirements from other product-country pages: compare the separate routes for U.S. face cream, hair dye in Japan and hair dye in South Korea.

Hair dye FAQ

Is natural henna automatically exempt from FDA color-additive rules?

No. FDA treats plant/mineral coloring materials differently from coal-tar hair dyes. Check the exact permitted coloring use and regulatory specifications, even for ingredients marketed as natural.

Can a very small permanent-hair-dye brand skip MoCRA product listing?

Not merely because it is small. A product changing appearance for more than 24 hours without customary consumer removal may exclude the statutory small-business exemption. Confirm the facts and the obligations of each facility and responsible person.

Does a Cosmetics Direct listing mean my dye is FDA certified?

No. FDA does not issue certificates confirming cosmetic facility registration or listing, and a listing number does not mean FDA approved the product.

May I sell a scalp-color formula as a brow tint?

Not on that basis. The coal-tar scalp-dye exception does not cover eyebrow or eyelash coloring; the specific silver-nitrate professional-use authorization is narrow and should be checked separately.

If our permanent dye is PPD-free, can we omit the patch-test warning?

Not automatically. First confirm that the actual coloring chemistry qualifies as a coal-tar hair dye. If it does, the statutory caution and adequate preliminary skin-test directions are conditions of the particular §601(a) safety-adulteration protection, regardless of “PPD-free” marketing; the separate §601(e) color-additive approval exception should not be confused with that condition.

Official sources

Responsible for publication: Khachatrian Razmik

Last updated: 2026-10-16

Related guidance